These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034 [TBL] [Abstract][Full Text] [Related]
4. Assay of the c-erbB-2 oncogene encoded protein by ELISA and immunocytochemistry in human breast cancer. Nugent A; Gallagher J; Dolan J; O'Higgins N; Duffy MJ Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():171-3. PubMed ID: 7914719 [TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492 [TBL] [Abstract][Full Text] [Related]
6. c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue. McCann A; Johnston PA; Dervan PA; Gullick WJ; Carney DN Ir J Med Sci; 1989 Jun; 158(6):137-40. PubMed ID: 2570047 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer. Horiguchi J; Iino Y; Takei H; Yokoe T; Ishida T; Morishita Y Oncology; 1994; 51(1):47-51. PubMed ID: 7903441 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997 [TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806 [TBL] [Abstract][Full Text] [Related]
11. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study. Gasparini G; Gullick WJ; Maluta S; Dalla Palma P; Caffo O; Leonardi E; Boracchi P; Pozza F; Lemoine NR; Bevilacqua P Eur J Cancer; 1994; 30A(1):16-22. PubMed ID: 7908213 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer. Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma. Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions. Pechoux C; Chardonnet Y; Noël P Anticancer Res; 1994; 14(3B):1343-60. PubMed ID: 7915095 [TBL] [Abstract][Full Text] [Related]
15. [Study of c-erbB-2 expression in breast neoplasms]. Ye F Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):104-6. PubMed ID: 8104720 [TBL] [Abstract][Full Text] [Related]
16. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay. Watanabe T; Fukutomi T; Tsuda H; Adachi I; Nanasawa T; Yamamoto H; Abe K Jpn J Cancer Res; 1993 Dec; 84(12):1279-86. PubMed ID: 7904987 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression. Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853 [TBL] [Abstract][Full Text] [Related]
19. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies]. Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262 [TBL] [Abstract][Full Text] [Related]
20. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas. Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]